Clinical trial NCT02388360 - References

Glaucoma, Open-Angle — The Impact of Topical Prostaglandins on the Biomechanical Properties of the Cornea in Patients With Open Angle Glaucoma

Citation(s)

•   Agarwal DR, Ehrlich JR, Shimmyo M, Radcliffe NM
  The relationship between corneal hysteresis and the magnitude of intraocular pressure reduction with topical prostaglandin therapy. Br J Ophthalmol. 2012 Feb;96(2):254-7. doi: 10.1136/bjo.2010.196899. Epub 2011 Mar 24.
•   Chronopoulos A, Tang A, Beglova E, Trackman PC, Roy S
  High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function. Diabetes. 2010 Dec;59(12):3159-66. doi: 10.2337/db10-0365. Epub 2010 Sep 7.
•   Congdon NG, Broman AT, Bandeen-Roche K, Grover D, Quigley HA
  Central corneal thickness and corneal hysteresis associated with glaucoma damage. Am J Ophthalmol. 2006 May;141(5):868-75. Epub 2006 Mar 9.
•   Detry-Morel M, Jamart J, Hautenauven F, Pourjavan S
  Comparison of the corneal biomechanical properties with the Ocular Response Analyzer® (ORA) in African and Caucasian normal subjects and patients with glaucoma. Acta Ophthalmol. 2012 Mar;90(2):e118-24. doi: 10.1111/j.1755-3768.2011.02274.x. Epub 2011 Oct 11.
•   Detry-Morel M, Jamart J, Pourjavan S
  Evaluation of corneal biomechanical properties with the Reichert Ocular Response Analyzer. Eur J Ophthalmol. 2011 Mar-Apr;21(2):138-48.
•   Glass DH, Roberts CJ, Litsky AS, Weber PA
  A viscoelastic biomechanical model of the cornea describing the effect of viscosity and elasticity on hysteresis. Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3919-26. doi: 10.1167/iovs.07-1321. Epub 2008 Jun 6.
•   Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Kass MA
  The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002 Jun;120(6):714-20; discussion 829-30.
•   He J, Bazan NG, Bazan HE
  Alkali-induced corneal stromal melting prevention by a novel platelet-activating factor receptor antagonist. Arch Ophthalmol. 2006 Jan;124(1):70-8.
•   Kataoka A, Tozaki-Saitoh H, Koga Y, Tsuda M, Inoue K
  Activation of P2X7 receptors induces CCL3 production in microglial cells through transcription factor NFAT. J Neurochem. 2009 Jan;108(1):115-25. doi: 10.1111/j.1471-4159.2008.05744.x. Epub 2008 Nov 10.
•   Lindsey JD, Kashiwagi K, Kashiwagi F, Weinreb RN
  Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow. Surv Ophthalmol. 1997 Feb;41 Suppl 2:S53-9. Review.
•   Lindsey JD, Kashiwagi K, Kashiwagi F, Weinreb RN
  Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest Ophthalmol Vis Sci. 1997 Oct;38(11):2214-23.
•   Lopilly Park HY, Kim JH, Lee KM, Park CK
  Effect of prostaglandin analogues on tear proteomics and expression of cytokines and matrix metalloproteinases in the conjunctiva and cornea. Exp Eye Res. 2012 Jan;94(1):13-21. doi: 10.1016/j.exer.2011.10.017. Epub 2011 Nov 4.
•   Luce DA
  Determining in vivo biomechanical properties of the cornea with an ocular response analyzer. J Cataract Refract Surg. 2005 Jan;31(1):156-62.
•   Mankus C, Chi C, Rich C, Ren R, Trinkaus-Randall V
  The P2X(7) receptor regulates proteoglycan expression in the corneal stroma. Mol Vis. 2012;18:128-38. Epub 2012 Jan 18.
•   Mathew JH, Bergmanson JP, Doughty MJ
  Fine structure of the interface between the anterior limiting lamina and the anterior stromal fibrils of the human cornea. Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3914-8. doi: 10.1167/iovs.07-0707.
•   Mayo C, Ren R, Rich C, Stepp MA, Trinkaus-Randall V
  Regulation by P2X7: epithelial migration and stromal organization in the cornea. Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4384-91. doi: 10.1167/iovs.08-1688. Epub 2008 May 23.
•   Ottino P, He J, Axelrad TW, Bazan HE
  PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts. Invest Ophthalmol Vis Sci. 2005 Feb;46(2):487-96.
•   Ottino P, Taheri F, Bazan HE
  Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2. Exp Eye Res. 2002 Mar;74(3):393-402.
•   Quigley HA, Broman AT
  The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006 Mar;90(3):262-7.
•   Roberts C
  Biomechanics of the cornea and wavefront-guided laser refractive surgery. J Refract Surg. 2002 Sep-Oct;18(5):S589-92.
•   Roberts C
  The cornea is not a piece of plastic. J Refract Surg. 2000 Jul-Aug;16(4):407-13. Review.
•   Sagara T, Gaton DD, Lindsey JD, Gabelt BT, Kaufman PL, Weinreb RN
  Topical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway. Arch Ophthalmol. 1999 Jun;117(6):794-801.
•   Scott JE, Dyne KM, Thomlinson AM, Ritchie M, Bateman J, Cetta G, Valli M
  Human cells unable to express decoron produced disorganized extracellular matrix lacking "shape modules" (interfibrillar proteoglycan bridges). Exp Cell Res. 1998 Aug 25;243(1):59-66.
•   Shah S, Laiquzzaman M, Cunliffe I, Mantry S
  The use of the Reichert ocular response analyser to establish the relationship between ocular hysteresis, corneal resistance factor and central corneal thickness in normal eyes. Cont Lens Anterior Eye. 2006 Dec;29(5):257-62. Epub 2006 Nov 7.
•   Tao Y, Bazan HE, Bazan NG
  Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium. Invest Ophthalmol Vis Sci. 1996 Sep;37(10):2037-46.
•   Terai N, Raiskup F, Haustein M, Pillunat LE, Spoerl E
  Identification of biomechanical properties of the cornea: the ocular response analyzer. Curr Eye Res. 2012 Jul;37(7):553-62. doi: 10.3109/02713683.2012.669007. Epub 2012 May 4. Review.
•   Touboul D, Roberts C, Kérautret J, Garra C, Maurice-Tison S, Saubusse E, Colin J
  Correlations between corneal hysteresis, intraocular pressure, and corneal central pachymetry. J Cataract Refract Surg. 2008 Apr;34(4):616-22. doi: 10.1016/j.jcrs.2007.11.051.
•   Tsikripis P, Papaconstantinou D, Koutsandrea C, Apostolopoulos M, Georgalas I
  The effect of prostaglandin analogs on the biomechanical properties and central thickness of the cornea of patients with open-angle glaucoma: a 3-year study on 108 eyes. Drug Des Devel Ther. 2013 Oct 4;7:1149-56. doi: 10.2147/DDDT.S50622. eCollection 2013.
•   Visse R, Nagase H
  Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003 May 2;92(8):827-39. Review.
•   Weinreb RN, Lindsey JD, Marchenko G, Marchenko N, Angert M, Strongin A
  Prostaglandin FP agonists alter metalloproteinase gene expression in sclera. Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4368-77.
•   Wells AP, Garway-Heath DF, Poostchi A, Wong T, Chan KC, Sachdev N
  Corneal hysteresis but not corneal thickness correlates with optic nerve surface compliance in glaucoma patients. Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3262-8. doi: 10.1167/iovs.07-1556. Epub 2008 Mar 3.

The Impact of Topical Prostaglandin Analogs on the Biomechanical Properties of the Cornea in Patients With Open Angle Glaucoma

Details for clinical trial NCT02388360